Mostrar el registro sencillo del ítem

dc.contributor.authorMartinón Torres, Federico 
dc.contributor.authorMartinon Torres, Nazareth 
dc.contributor.authorBouzón Alejandro, Marta 
dc.contributor.authorRedondo Collazo, Lorenzo 
dc.contributor.authorPertega-Diaz, S
dc.contributor.authorSeoane-Pillado, M T
dc.contributor.authorAboal Viñas, Jorge 
dc.contributor.authorSan-Martin, M
dc.date.accessioned2017-06-07T07:20:10Z
dc.date.available2017-06-07T07:20:10Z
dc.date.issued2012
dc.identifier.issn2164-5515
dc.identifier.urihttp://hdl.handle.net/20.500.11940/5252
dc.description.abstractRotavirus vaccines were licensed in Spain between late 2006 and early 2007. Rotavirus vaccination was recommended but not reimbursed by the Spanish National Health System. Significant coverage rates have been reached in Galicia, with an average of 47% since the period July 2007-June 2008. We aim to explore eventual variations in the incidence of hospitalizations for acute gastroenteritis (AGE) among children < 5 y of age before and after vaccine introduction. The annual and monthly hospitalization rates for rotavirus-related AGE and all cause AGE, before and after rotavirus vaccine introduction, were calculated by using the official surveillance system for hospital data. The annual hospitalization rates for rotavirus-related AGE in children < 5 y of age decreased by 14.8% for the period July 2008 to June 2009 and by 44.5% for the period July 2009 to June 2010 as compared with the median rate of the pre-vaccination period (July 2003 to June 2007). The corresponding decreases for all cause AGE were 29.9% and 49.0%, respectively. In children < 12 mo of age a more marked decrease was observed. Compared with pre-vaccination years, a decrease in rotavirus-related and all cause AGE hospitalization rates was observed, with a greater decline in the July 2009 to June 2010 period
dc.language.isoeng
dc.titleAcute gastroenteritis hospitalizations among children aged < 5 years before and after introduction of rotavirus vaccines: A hospital-based surveillance study in Galicia, Spain
dc.typeArtigoes
dc.authorsophosMartinon-Torres, F
dc.authorsophosMartinon-Torres, N
dc.authorsophosAlejandro, M B
dc.authorsophosCollazo, L R
dc.authorsophosPertega-Diaz, S
dc.authorsophosSeoane-Pillado, M T
dc.authorsophosVinas, J A
dc.authorsophosSan-Martin, M
dc.authorsophosMartinón-Torres, F
dc.authorsophosMartinón-Torres, N
dc.authorsophosPértega-Díaz, S
dc.authorsophosViñas, J A
dc.authorsophosSan-Martín, M
dc.identifier.doihttp://dx.doi.org/10.4161/hv.20178
dc.identifier.isi307107600022
dc.identifier.pmid22484280
dc.identifier.sophos8603
dc.issue.number7
dc.journal.titleHuman Vaccines & Immunotherapeutics 
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago - Complexo Hospitalario Universitario de Santiago::Pediatría
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago::IDIS.- Instituto de investigaciones sanitarias de Santiago
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago - Complexo Hospitalario Universitario de Santiago::Admisión e documentación clínica
dc.page.initial946
dc.page.final952
dc.rights.accessRightsopenAccess
dc.typesophosArtículo Original
dc.volume.number8 (7)


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem